用等离子体增强的双交联Pueraria水凝涂层用于协同性动脉样硬化干预
Jingyue Wang1,2, Ge Yin3, Leila Mamizadeh Janghour4
1Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, Sichuan, China.
Materials today. Bio
|October 2, 2025
概括
这项研究提出了一种新的双交联凝涂层,用于动脉样硬化干预,提高支架性能并促进愈合. 基于Pueraria多糖的涂层提供了更好的机械稳定性和受控的药物释放,以改善患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 医疗设备工程 医疗设备工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 支架血栓和复缩仍然是动脉样硬化干预的重大挑战.
- 现有的治疗方法往往缺乏足够的疗效和生物相容性.
- 需要先进的支架涂层来促进愈合和预防不良事件.
研究的目的:
- 为316L不钢支架开发一种新的双交联凝涂层.
- 整合Pueraria lobata的多糖衍生物,以增强治疗效果.
- 为了提高支架的生物相容性,机械稳定性和抗缩性质.
主要方法:
- 利用离子辅助等离子聚合 (IAPP) 来创建微纳米表面结构.
- 采用乙烯点击化学,用于水凝涂层的强大的共价集成.
- 开发了一种双网络水凝架构,具有协同协同和动态交叉连接.
主要成果:
- PSMASH涂层表现出增强的机械稳定性和受控的降解.
- 涂层促进了内皮细胞的恢复,并调节了光滑肌肉细胞表型.
- 控制释放的Pueraria衍生的黄类药物调解了观察到的治疗效果.
结论:
- 开发的"草药到设备" (HTD) 战略为动脉样硬化干预提供了一个新的治疗平台.
- 该PSMASH涂层提供卓越的机械兼容性和多目标协同效率.
- 这种方法代表了设计用于心血管疾病的先进医疗设备的重大进步.
相关概念视频
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
01:27Peripheral Artery Disease III: Interprofessional Care
245
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245